SA

Sameer Arjun Kasbe

Active Director Director DIN 09468011
DIN 09468011 First appointment Jan 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2022
Shareholding value •••• Premium profile

About Sameer Arjun Kasbe

Data last updated:

Sameer Arjun Kasbe is a Director at Medatec Pharmaceuticals Private Limited (since 2022). The company operates in Chemicals. Medatec Pharmaceuticals Private Limited reported revenue of ₹10.3 Lakh (FY 2025).

DIN 09468011
Primary Designation Director
Industry Chemicals
First Appointment 14 Jan 2022
Oldest Company Age 4 yrs
Largest company Medatec Pharmaceuticals Private Limited · ₹10.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Jan 20222022₹10.3 Lakh (FY 2025)Active

Board colleagues of Sameer Arjun Kasbe

NameDINCompanyDesignation
Sameer Preeti Kasbe10541076Medatec Pharmaceuticals Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Medatec Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sameer Arjun Kasbe

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sameer Arjun Kasbe

Sameer Arjun Kasbe currently holds 1 directorship: Medatec Pharmaceuticals Private Limited (Director, since 14 Jan 2022, revenue ₹10.3 Lakh (FY 2025)).

Sameer Arjun Kasbe was first appointed on 14 Jan 2022 as Director at Medatec Pharmaceuticals Private Limited.

The current boards of Sameer Arjun Kasbe's companies include Sameer Preeti Kasbe (Medatec Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available